Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HANOVER INSURANCE GROUP, INC.THG · Entity 3652 | Director · President & CEO | February 24, 2017 | February 28, 2017 |
| MOLINA HEALTHCARE, INC.MOH · Entity 3504 | Director · President & CEO | March 01, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HANOVER INSURANCE GROUP, INC.
Report date February 24, 2017 · Filed February 28, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $91.19 · Expires 2027-02-24 | Direct | 114,165 |
Reported balance
After 2017-02-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-02-24 · Grant · Acquired 114,165 · Balance 114,165 F1: Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date.
MOLINA HEALTHCARE, INC.
Report date March 01, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 32,598 |
Reported balance
After 2026-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-01 · Tax withholding · Disposed 8,597 · Balance 32,598 F1: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 20,623 shares on March 1, 2026. F2: Represents the closing price of the Issuer's common stock on February 27, 2026. |
| Common StockSEC Table I · non-derivative | Direct | 99,015 |
Reported balance
After 2026-03-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-01 · Grant · Acquired 66,417 · Balance 99,015 F3: Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan. F4: Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date. F5: The shares shall vest as follows: The 66,417 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 13,075 shares on March 1, 2027; and 7,497 shares on March 1, 2028. The remaining shares are vested. |
| Common StockSEC Table I · non-derivative | IndirectHeld by Trust | 257,715 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 257,715 F6: Shares are held by Joseph M. Zubretsky Revocable Trust, of which Joseph M. Zubretsky is the sole trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 20,623 shares on March 1, 2026.
F2: Represents the closing price of the Issuer's common stock on February 27, 2026.
F3: Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan.
F4: Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date.
F5: The shares shall vest as follows: The 66,417 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 13,075 shares on March 1, 2027; and 7,497 shares on March 1, 2028. The remaining shares are vested.
F6: Shares are held by Joseph M. Zubretsky Revocable Trust, of which Joseph M. Zubretsky is the sole trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2026 Filed Mar 3, 2026 01:07 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 66,417 | $145.75 | $9,680,277.75 |
DisclosureSEC source: 0001320929-26-000002 · wk-form4_1772500032.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,015 F3 · shares: Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan. F4 · price: Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date. F5 · balance_after: The shares shall vest as follows: The 66,417 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 13,075 shares on March 1, 2027; and 7,497 shares on March 1, 2028. The remaining shares are vested. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 01:07 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 8,597 | $154.05 | $1,324,367.85 |
DisclosureSEC source: 0001320929-26-000002 · wk-form4_1772500032.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,598 F1 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 20,623 shares on March 1, 2026. F2 · price: Represents the closing price of the Issuer's common stock on February 27, 2026. Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:34 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,100 | $324.70 | $357,170.00 |
DisclosureSEC source: 0001179929-25-000081 · wk-form4_1746218084.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 257,715 F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $324.22 to $324.84. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Shares are held by Joseph M. Zubretsky Revocable Trust, of which Joseph M. Zubretsky is the sole trustee. Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:34 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 86,400 | $320.00 | $27,648,000.00 |
DisclosureSEC source: 0001179929-25-000081 · wk-form4_1746218084.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 258,815 F1 · shares: The reported securities were sold in a block sale at a per share price of $320.00. F2 · ownership.nature: Shares are held by Joseph M. Zubretsky Revocable Trust, of which Joseph M. Zubretsky is the sole trustee. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 01:20 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 22,491 | $288.12 | $6,480,106.92 |
DisclosureSEC source: 0001179929-25-000033 · wk-form4_1741137624.xml · nonDerivative · entry 4 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,410 F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F6 · price: The volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2025 grant date. F7 · balance_after: The shares shall vest as follows: The 22,491 newly granted shares shall vest in one-third increments on each of March 1, 2026, March 1, 2027, and March 1, 2028. Additional shares shall vest as follows: 13,127 shares on March 1, 2026 and 5,577 shares on March 1, 2027. The remaining shares are vested. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 01:20 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 9,036 | $301.12 | $2,720,920.32 |
DisclosureSEC source: 0001179929-25-000033 · wk-form4_1741137624.xml · nonDerivative · entry 3 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,919 F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 19,539 shares on March 1, 2025. F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 01:20 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 19,993 | $301.12 | $6,020,292.16 |
DisclosureSEC source: 0001179929-25-000033 · wk-form4_1741137624.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,955 F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 01:20 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 42,996 | $301.12 | $12,946,955.52 |
DisclosureSEC source: 0001179929-25-000033 · wk-form4_1741137624.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,948 F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2022 based on the Company achievement of three-year average adjusted earnings per share at the 149% vesting level for the 2022 performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:37 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 16,735 | $387.21 | $6,479,959.35 |
DisclosureSEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 4 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,952 F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. F6 · balance_after: The shares shall vest as follows: The 16,735 newly granted shares shall vest in one-third on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 13,960 shares shall vest on March 1, 2025; and 7,548 shares shall vest on March 1, 2026. The remaining shares are vested. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:37 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 27,374 | $387.21 | $10,599,486.54 |
DisclosureSEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 3 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,217 F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 22,960 shares on March 1, 2024. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:37 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 32,069 | $387.21 | $12,417,437.49 |
DisclosureSEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,591 F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:37 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 68,844 | $387.21 | $26,657,085.24 |
DisclosureSEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,660 F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| November 21, 2023 Filed Nov 25, 2023 00:40 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GiftCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179929-23-000137 · wk-form4_1700872822.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,816 F1 · kind: Reflects the gift of common stock to a charitable donor advised fund. F2 · price: Price not applicable to gift. F3 · balance_after: 22,960 shares vest on March 1, 2024; 13,960 shares vest on March 1, 2025; and 7,548shares vest on March 1, 2026. The remainder of the shares are vested. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 64,112 | $273.80 | $17,553,865.60 |
DisclosureSEC source: 0001179929-23-000037 · wf-form4_167788597108581.xml · nonDerivative · entry 4 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,516 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. F6 · balance_after: Shares shall vest as follows: the 22,644 newly granted shares shall vest in one-third increments on each of March 1, 2024, March 1, 2025, and March 1, 2026. Additional shares shall vest as follows: 15,412 shares vest on March 1, 2024 and 6,412 shares vest on March 1, 2025. The remainder of the shares are vested. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 134,638 | $273.80 | $36,863,884.40 |
DisclosureSEC source: 0001179929-23-000037 · wf-form4_167788597108581.xml · nonDerivative · entry 3 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,628 F4 · kind: Shares issued in settlement of performance stock units granted in 2020 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2020, 2021, and 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 22,644 | $273.08 | $6,183,623.52 |
DisclosureSEC source: 0001179929-23-000037 · wf-form4_167788597108581.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,990 F3 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 14,211 | $273.80 | $3,890,971.80 |
DisclosureSEC source: 0001179929-23-000037 · wf-form4_167788597108581.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,346 F1 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 30,372 shares on March 1, 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 22:56 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GiftCommon Stock | 4,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179929-22-000182 · wf-form4_166993537337088.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,557 F1 · kind: Reflects the gift of common stock to a charitable donor advised fund. F2 · price: Price not applicable to gift. F3 · balance_after: 30,372 shares vest on March 1, 2023; 15,412 shares vest on March 1, 2024; 6,412 shares vest on March 1, 2025. The remainder of the shares are vested. Read SEC document |
| October 07, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 28,914 | $0.00 Strike: $67.33 | $0.00 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · derivative · entry 26 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,914 shares Expires 2027-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F23 · derivative.exercise_date: The options are fully vested. Read SEC document |
| October 07, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,412 | $348.85 | $492,576.06 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 23 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,157 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F21 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $348.73 to $349.14. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. F22 · balance_after: 30,372 shares vest on March 1, 2023; 15,412 shares vest on March 1, 2024; 6,412 shares vest on March 1, 2025. The remainder of the shares are vested. Read SEC document |
| October 07, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 5,403 | $348.24 | $1,881,533.16 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 22 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,569 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F20 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $347.73 to $348.71. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 07, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 6,031 | $347.23 | $2,094,123.62 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 21 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,972 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F19 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $346.72 to $347.71. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 07, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 8,137 | $346.16 | $2,816,690.09 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 20 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,003 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F18 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $345.71 to $346.69. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 07, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 4,503 | $345.20 | $1,554,426.14 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 19 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,140 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F17 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $344.70 to $345.63. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 07, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,323 | $344.32 | $799,846.53 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 18 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,643 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F16 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $343.68 to $344.67. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 07, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,105 | $342.95 | $378,963.40 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 17 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,966 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F15 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $342.52 to $343.39. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 07, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 28,914 | $67.33 | $1,946,779.62 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 16 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $67.33 | $0.00 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · derivative · entry 25 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,914 Underlying: Common Stock · 30,000 shares Expires 2027-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F23 · derivative.exercise_date: The options are fully vested. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,700 | $356.32 | $962,064.54 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 15 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,157 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F14 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $356.15 to $356.67. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 9,977 | $355.49 | $3,546,678.83 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 14 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,857 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F13 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $355.13 to $356.11. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 9,423 | $354.61 | $3,341,518.30 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 13 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,834 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F12 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $354.13 to $355.11. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 5,669 | $353.70 | $2,005,123.60 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 12 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,257 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F11 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $353.13 to $354.10. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,231 | $352.61 | $786,676.03 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 11 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,926 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F10 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $352.13 to $353.12. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 30,000 | $67.33 | $2,019,900.00 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 10 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $67.33 | $0.00 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · derivative · entry 24 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,914 Underlying: Common Stock · 30,000 shares Expires 2027-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F23 · derivative.exercise_date: The options are fully vested. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,444 | $352.83 | $509,487.82 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 9 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,157 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F9 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $352.54 to $352.99. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,657 | $351.73 | $934,537.58 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 8 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,601 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F8 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $351.25 to $352.13. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,114 | $350.60 | $1,091,759.37 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 7 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,258 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F7 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $350.20 to $350.95. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 5,266 | $349.50 | $1,840,461.73 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 6 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,372 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F6 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $349.15 to $350.12. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 7,265 | $348.62 | $2,532,701.05 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 5 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,638 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F5 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $348.15 to $349.13. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,123 | $347.70 | $1,085,852.11 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 4 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,903 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F4 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $347.11 to $348.08. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 4,200 | $346.71 | $1,456,202.58 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 3 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,026 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $346.11 to $347.10. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,931 | $345.73 | $1,013,348.70 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,226 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $345.11 to $345.95. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 30,000 | $67.33 | $2,019,900.00 |
DisclosureSEC source: 0001179929-22-000167 · wf-form4_166518522666695.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 02:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $67.33 | $0.00 |
DisclosureSEC source: 0001179929-22-000156 · wf-form4_166493323238207.xml · derivative · entry 31 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,914 Underlying: Common Stock · 30,000 shares Expires 2027-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F28 · derivative.exercise_date: The options are fully vested. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 02:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,180 | $346.74 | $755,898.43 |
DisclosureSEC source: 0001179929-22-000156 · wf-form4_166493323238207.xml · nonDerivative · entry 28 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,157 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F27 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $346.30 to $346.93. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 02:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 6,823 | $345.67 | $2,358,509.82 |
DisclosureSEC source: 0001179929-22-000156 · wf-form4_166493323238207.xml · nonDerivative · entry 27 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,337 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F26 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $345.27 to $346.25. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 02:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 7,873 | $344.66 | $2,713,482.99 |
DisclosureSEC source: 0001179929-22-000156 · wf-form4_166493323238207.xml · nonDerivative · entry 26 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,160 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F25 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $344.26 to $345.24. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 02:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 8,825 | $343.72 | $3,033,305.17 |
DisclosureSEC source: 0001179929-22-000156 · wf-form4_166493323238207.xml · nonDerivative · entry 25 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,033 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F24 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $343.25 to $344.23. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 02:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,067 | $343.06 | $1,052,157.05 |
DisclosureSEC source: 0001179929-22-000156 · wf-form4_166493323238207.xml · nonDerivative · entry 24 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,858 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F23 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $342.24 to $343.23. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.